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ABSTRACT: We study the behavior of multicomponent giant
unilamellar vesicles (GUVs) in the presence of AzoTAB, a photo-
sensitive surfactant. GUVs are made of an equimolar ratio of
dioleoylphosphatidylcholine (DOPC) and dipalmitoylphosphatidylcho-
line (DPPC) and various amounts of cholesterol (Chol), where the lipid
membrane shows a phase separation into a DPPC-rich liquid-ordered
(Lo) phase and a DOPC-rich liquid-disordered (Ld) phase. We find that
UV illumination at 365 nm for 1 s induces the bursting of a significant
fraction of the GUV population. The percentage of UV-induced disrupted vesicles, called bursting rate (Yburst), increases with an
increase in [AzoTAB] and depends on [Chol] in a non-monotonous manner. Yburst decreases when [Chol] increases from 0 to 10
mol % and then increases with a further increase in [Chol], which can be correlated with the phase composition of the
membrane. We show that Yburst increases with the appearance of solid domains ([Chol] = 0) or with an increase in area fraction
of Lo phase (with increasing [Chol] ≥ 10 mol %). Under our conditions (UV illumination at 365 nm for 1 s), maximal bursting
efficiency (Yburst = 53%) is obtained for [AzoTAB] = 1 mM and [Chol] = 40 mol %. Finally, by restricting the illumination area,
we demonstrate the first selective UV-induced bursting of individual target GUVs. These results show a new method to probe
biomembrane mechanical properties using light as well as pave the way for novel strategies of light-induced drug delivery.
■ INTRODUCTION
Giant unilamellar vesicles (GUVs) are spherical entities with a
diameter in the range 1−100 μm, which have attracted a
growing interest for a large variety of biological and chemical
applications.
1−3 GUVs made of lipids can be used as
biomimetic cell-sized reactors
4−7 or model membrane
systems.
8−12 In the latter case, multicomponent lipid
membranes are particularly interesting for their similarity with
biological membranes.
13−19 Since GUVs are large enough to
allow direct microscopic observation of the membrane
behavior, investigations have been carried out on morphological
dynamics in response to various stimuli, such as temperature,
20
chemical reaction,
21 osmotic stress,
22−25 addition of deter-
gent,
23,26 and magnetic field.
27 Light represents another
particularly interesting stimulus as it offers high spatiotemporal
resolution, excitation tunability, and contactless perturbation.
The response of vesicles to light stimulation in the presence of
various kinds of photosensitive molecules has been studied in
the past few years, but it has been mainly limited to nonlipidic
vesicles. For instance, in the case of catanionic small unilamellar
vesicles (SUV), light has been used to trigger the disruption
and the reformation of SUVs using a cationic
28−30 or an
anionic
31 photosensitive surfactant. The light-induced dis-
ruption of GUVs containing a cationic photosensitive gemini
surfactant
32,33 as well as of polymerosomes made of photo-
sensitive diblock copolymers has also been reported.
34,35 In
contrast, few studies have been devoted to the interaction
between light and vesicles with a lipid membrane. In the case of
SUVs, wavelength-dependent structures using photoisomeriz-
able lipids
36−39 and light-induced permeation using photo-
sentive surfactants
40,41 or a photoreticulable lipid
42 have been
demonstrated. In the case of GUVs made of phospholipids,
light-induced shape transitions in the presence of pyrene,
43
deformations,
44−46 and membrane phase separation
47 in
vesicles containing a high concentration (≈40 mol %) of a
photosensitive bolaphile in the membrane or permeability
variations in the presence of a photosensitive amphiphilic
polymer
48 have been reported. In this article, we report for the
first time the effect of light applied on GUVs solely composed
of natural lipids [dioleoylphosphatidylcholine (DOPC),
dipalmitoylphosphatidylcholine (DPPC), cholesterol (Chol)]
in the presence of a photosensitive azobenzene surfactant
(AzoTAB) added to the outer medium of vesicles. We found
that a short UV stimulation (365 nm for 1 s) induces
immediate bursting of GUVs. We studied the effect of
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concentration on the yield of bursting. We also applied local
light stimulation for selective destruction of target individual
GUVs among others.
■ RESULTS
Figure 1 shows our experimental system. We used an
azobenzene trimethylammonium bromide surfactant (Azo-
TAB) as a photosensitive surfactant. Under dark conditions,
AzoTAB is mainly in the trans configuration, which has a linear
and apolar hydrophobic tail. Upon UV illumination (365 nm)
trans-AzoTAB photoisomerizes into cis configuration, which
has a bent and more polar tail. cis-AzoTAB is stable and can be
kept under dark conditions for several hours.
49 The system is
reversible, and cis-AzoTAB isomerizes back to trans config-
uration upon blue light (475 nm) illumination (Figure 1A).
AzoTAB has been mainly used for the photocontrol of surface
tension,
50,51 DNA conformation,
49,52,53 and gene expression
systems.
54−56 Here, we investigated how light affected the
behavior of lipid GUVs in the presence of AzoTAB. For all
experiments the GUV membrane was composed of an
equimolar mixture of DOPC and DPPC and different fractions
of Chol, which is a standard composition for a multicomponent
model membrane system.
16 At room temperature, in the
absence of cholesterol, DPPC is in the gel phase and forms
solid domains, as shown in Figure 1B (left), where rhodamine-
DPPE (red) and perylene (blue) are both excluded from the
noncircular, solid domains. In the presence of cholesterol
([Chol] ≥ 10 mol %), the membrane separates into two
phases: a DPPC- and Chol-rich liquid-ordered (Lo) phase and a
DOPC-rich liquid-disordered (Ld) phase, as shown in Figure
1B (right), where rhodamine-DPPE (red) and perylene (blue)
are localized in Ld and Lo phases, respectively.
15 GUVs were
prepared by electroformation in a 0.1 M sucrose solution. After
electroformation, GUVs were mixed with an AzoTAB solution
in glucose having the same osmolarity as that of the sucrose
solution. After 2 h of sedimentation due to weight density
difference between sucrose and glucose, most of vesicles were
collected at the bottom of a chamber and observed by phase
contrast microscopy, before and after illumination by UV (365
nm) or blue (475 nm) light for 1 s (Figure 1C).
We first observed that the application of UV on GUVs in the
presence of AzoTAB resulted in the bursting of a significant
fraction of GUVs (Figure 2A and movie S1, Supporting
Information). Time lapse observations of individual bursting
events showed that bursting typically occurs within a few
hundreds of milliseconds (Figure 2B). To our knowledge, this
Figure 1. Light stimulation of multicomponent giant unilamellar
vesicles (GUVs) in the presence of AzoTAB photosensitive surfactant.
(A) Molecular structure and photoisomerization of AzoTAB. Upon
UV illumination at λ = 365 nm, AzoTAB isomerizes to cis
configuration, resulting in a more polar and bent tail. The process is
reversible upon visible light illumination at λ = 475 nm, resulting in the
isomerization into trans configuration. (B) Confocal microscopy
images of GUVs made of 1:1 DOPC/DPPC with [Chol] = 0 and 10
mol % (left and right, respectively). Domains in liquid-disordered (Ld)
and liquid-ordered (Lo) phase are labeled in red using rhodamine-
DPPE (2 mol %) and blue using perylene (0.5 mol %), respectively.
Dark regions in the left picture indicate a solid phase where both dyes
are fully excluded. Scale bars are 10 μm. (C) A suspension of GUVs in
sucrose is mixed with an AzoTAB solution in glucose having the same
osmolarity. After 2 h of sedimentation, GUVs are observed and
illuminated by UV (365 nm) or blue (475 nm) light for 1 s using an
inverted microscope.
Figure 2. UV-induced bursting of GUVs. (A) Phase contrast
microscopy images of GUVs made of 1:1 DOPC/DPPC and
cholesterol (40 mol %) in the presence of AzoTAB (1 mM), before
(left) and after (right) application of UV (365 nm for 1 s). Scale bar is
200 μm. (B) Timelapse observation by phase contrast microscopy of
an individual GUV under an UV illumination (365 nm) started at t =
0. Scale bar is 30 μm.
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composed of lipids is reported.
We then systematically measured the bursting rate, Yburst,
defined as the percentage of GUVs that were destroyed by UV
illumination (365 nm for 1 s). Figure 3 shows Yburst as function
of cholesterol fraction in the membrane ([Chol]) and AzoTAB
concentration in the outer medium of vesicles ([AzoTAB]).
Figure 3 shows that regardless of cholesterol content, AzoTAB
has a strong influence on the yield of bursting. Without
AzoTAB, most of vesicles remain intact after UV illumination
(Yburst ≤ 3%). In contrast, in the presence of AzoTAB, a
significant fraction of vesicles burst upon UV illumination, and
Yburst increases with an increase in [AzoTAB]. This shows that
under our experimental conditions, AzoTAB is needed for UV-
induced bursting. Notably, Figure 3 shows also a non-
monotonous behavior as a function of cholesterol content.
Regardless of [AzoTAB] ≥ 0.25 mM, Yburst shows a marked
drop when [Chol] increases from 0 to 10 mol % and then
increases when [Chol] increases from 10 to 40 mol %. All these
results show that the presence of both AzoTAB and membrane
composition have a role in the extent of bursting upon UV
illumination. The maximum bursting rate is 53%, which is
obtained for [AzoTAB] = 1 mM and [Chol] = 40 mol %.
■ DISCUSSION
We showed that AzoTAB had a critical role in both occurrence
and extent of UV-induced bursting. To correlate this effect with
the isomerization properties of AzoTAB, we studied the effect
of AzoTAB configuration (cis or trans) and isomerization (cis−
trans or trans−cis) on illumination-induced bursting under
conditions where maximal bursting rate was observed
([AzoTAB] 1 mM, [Chol] = 40 mol %). First, AzoTAB
solution was exposed to UV to get cis-AzoTAB in solution prior
to addition to GUVs in the dark. When UV (365 nm for 1 s)
was applied, AzoTAB remained in the cis configuration, and no
bursting was observed (Figure 4A, left and middle). This shows
that UV illumination by itself does not induce GUV bursting.
When blue light (475 nm for 1 s) was applied on the same
sample, cis-AzoTAB isomerized to trans configuration, and no
bursting was observed (Figure 4A, middle and right). This
shows that cis−trans isomerization is not responsible of
bursting. We then added trans-AzoTAB solution to a new
GUV solution. When blue light was applied, AzoTAB remained
in trans configuration, and no bursting was observed (Figure
4B, left and middle). This shows that illumination-induced
bursting in the presence of AzoTAB is dependent on
wavelength illumination and is not due to a thermal effect.
When UV was applied on this sample, trans-AzoTAB
isomerized to cis configuration, and the usual UV-induced
bursting was observed (Figure 4B, middle and right). All these
results show that both the presence of trans-AzoTAB in the
initial solution and UV-induced trans−cis isomerization are
necessary to observe UV-induced bursting.
The role of the configuration of AzoTAB (trans or cis) might
be attributed to different affinities for the GUV membrane
between trans and cis isomers. To assess the insertion of
AzoTAB in GUV membrane and compare the affinities
between trans and cis isomers, we performed UV−vis
spectroscopy measurements on GUVs prepared under the
conditions of maximal bursting ([AzoTAB] = 1 mM and
[Chol] = 40 mol %). GUVs were first incubated with AzoTAB
(1 mM), then concentrated by centrifugation, washed with
glucose to remove most of AzoTAB from the bulk solution, and
concentrated again by centrifugation (Figure 5A). Figure 5B,C
shows the UV−vis spectra for trans-a n dcis-AzoTAB,
respectively. Both isomers have spectra similar to those
measured in pure water
53 with a characteristic maximum at
354 nm for trans and 319 and 430 nm for cis. The absorbance
values for the lower phase in the absence of GUVs and for the
upper phase are very similar and approximately correspond to
the remaining amount of AzoTAB in the outer medium of
GUVs after washing. Interestingly, in the case of trans-AzoTAB
(Figure 5B), the lower phase in the presence of GUVs shows a
significantly higher absorption, which shows that GUV
membranes have accumulated trans-AzoTAB during incubation.
Moreover, UV application on this sample induces the
isomerization from trans to cis isomer (Figure S1, Supporting
Information), which shows that, under our experimental
conditions, UV-induced isomerization occurs in the membrane.
A very different situation is observed with cis-AzoTAB (Figure
5C), where the absorption of the lower phase in the presence of
GUVs is very similar to the control experiments (lower phase in
the absence of GUV and upper phase with GUVs). This shows
Figure 3. Effect of AzoTAB and cholesterol on UV-induced bursting
rate. Percentage of GUVs disrupted after UV illumination (365 nm for
1 s), called bursting rate (Yburst), as a function of AzoTAB
concentration and cholesterol (Chol) composition of the membrane.
Figure 4. Effect of UV and blue light illumination in the presence of
cis-o rtrans-AzoTAB. Phase contrast microscopy images of GUVs
before and after UV (365 nm for 1 s) or blue (475 nm for 1 s)
illumination initially in the presence of (A) cis-AzoTAB or (B) trans-
AzoTAB. GUVs are made of 1:1 DOPC/DPPC and 40 mol %
cholesterol, with [AzoTAB] = 1 mM. Scale bars are 200 μm.
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AzoTAB in GUV membranes. The different affinities for
membranes between trans- and cis-AzoTAB can be explained as
follows. The tail of trans-AzoTAB is apolar and more
hydrophobic than that of cis-AzoTAB (Figure 1A), which is
confirmed by critical micellar concentrations (CMC) measure-
ments (CMC = 12.6 and 14.6 mM for trans and cis isomers,
respectively).
53 Moreover, trans-AzoTAB has a linear tail, while
cis-AzoTAB has a bent configuration. As a result, trans-AzoTAB
is more prone to insert in the hydrophobic bilayered membrane
of GUVs. If cis-AzoTAB has no or few interaction with the
GUV membrane, UV or visible light illumination has almost no
effect on GUVs initially in the presence of cis-AzoTAB (Figure
4A). In contrast, trans-AzoTAB is hydrophobic enough to
insert in GUV membrane without disrupting it. Consequently,
blue light has no effect (no isomerization), but UV induces a
trans to cis isomerization of all AzoTAB molecules, including
those inserted in the membrane (Figure S1, Supporting
Information). The isomerization of AzoTAB inside GUV
membrane may disturb the organization of phospholipid to an
extent that is sufficient to induce membrane rupture and vesicle
bursting (Figures 2,3,4B).
Since the perturbation of the phospholipid organization
seems to be responsible for the GUV bursting, it is interesting
to see how this effect is affected by the membrane composition.
In our experiments, we kept an equimolar ratio of DOPC/
DPPC and varied the fraction of cholesterol from 0 to 40 mol
%. Figure 3 shows that cholesterol fraction has a dramatic effect
on the bursting rate. In the absence of cholesterol, DPPC is in
the gel phase and forms solid domains (Figure 1B, left). In
contrast, in the presence of a small fraction of cholesterol
([Chol] = 10 mol %), there is no solid domain anymore, and
the GUV membrane shows two coexisting liquid phases: a
DPPC- and Chol-rich Lo phase that is shown in blue, and a
DOPC-rich Ld phase that is shown in red (Figure 1B, right),
which is in agreement with previous reports on DOPC/DPPC/
Chol systems.
14,16,57 Interestingly, this transition in DPPC-rich
phase from gel phase to Lo phase is accompanied by a sharp
drop in bursting rate (Figure 3). For instance, when [Chol]
increases from 0 to 10 mol %, Yburst drops from 30% and 45% to
11% and 21% for [AzoTAB] = 0.5 mM and 1 mM, respectively.
Saturated lipids, such as DPPC, in gel phase are known to have
a high area compressibility modulus (KA ≈ 800 mN·m−1),
58
while for DOPC in a liquid phase KA ≈ 250 mN·m−1.
59 The
presence of a small amount of cholesterol disrupts the long-
range lateral order of DPPC lipids in solid domains, which
fluidizes the membrane and induces a decrease in KA (KA ≈ 400
mN·m−1 for DPPC vesicles with [Chol] ≤ 15 mol %).
60 We
can thus suggest that, in response to AzoTAB isomerization,
phospholipids present in a liquid-state membrane, that is, in the
presence of a small amount of cholesterol, reorganize more
easily than when solid domains exist. As a result, GUVs are
Figure 5. Characterization of AzoTAB insertion in GUV membrane by UV−vis spectroscopy. (A) 500 μL of a sucrose solution (0.1 M) with or
without GUVs is mixed with 500 μL of glucose (0.1 M) containing AzoTAB (2 mM), incubated for 30 min in the dark, and centrifuged at 2000 rpm
for 10 min prior to removal of the upper phase solution. The lower phase is then washed with 1 mL of glucose (0.1 M) and centrifuged at 2000 rpm
for 10 min. To establish the UV−vis absorption spectra, 30 μL of the lower or upper phase is mixed with 100 μL of sucrose (0.1 M). Sucrose/glucose
with or without AzoTAB are adjusted to have the same osmolarity. (B−C) UV−vis absorption spectra of the lower and upper phases, in the presence
or absence of GUVs for (B) trans-AzoTAB and (C) cis-AzoTAB, respectively.
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not contain cholesterol, that is, when solid domains exist. In the
presence of cholesterol, the opposite trend is observed. The
bursting rate increases with an increase in cholesterol content
(Figure 3). To better understand this effect, we observed a large
number of GUVs by confocal microscopy (Figure 6A) and
estimated the area fraction of Lo phase (Figure 6B) as a
function of [Chol]. Figure 6A,B shows that the area fraction of
Lo phase increases from 38 ± 6% to 57 ± 2% when [Chol]
increases from 10 to 40 mol %, which is in agreement with
former reports.
14,16,57 It is thus interesting to correlate the
bursting yield with the fraction of Lo phase. Figure 6C shows
that almost no bursting occurs in the absence of AzoTAB,
which confirms that AzoTAB is needed for bursting to occur.
For a given fraction in Lo phase, Yburst increases with an increase
in AzoTAB concentration. Phospholipids have to reorganize in
response to the UV-induced isomerization of AzoTAB, and the
increase in Yburst with [AzoTAB] can be attributed to a higher
perturbation when AzoTAB concentration increases. Interest-
ingly, Figure 6C also shows that in the presence of AzoTAB,
the bursting yield increases with an increase in fraction of Lo
phase, regardless of AzoTAB concentration. This effect can be
attributed to the lower fluidity of the Lo phase (KA ≈ 1100−
1300 mN·m−1 for DPPC vesicles with [Chol] = 20−40 mol
%)
60 compared to the Ld phase (KA ≈ 250 mN·m−1 for pure
DOPC).
59 Phospholipids reorganization in response to the UV-
Figure 6. Effect of membrane phase composition. (A) Confocal microscopy images of GUVs composed of 1:1 DOPC/DPPC and various fractions
of cholesterol (Chol). Domains in Ld and Lo phases are labeled in red using rhodamine-DPPE (2 mol %) and blue using perylene (0.5 mol %),
respectively. Scale bars are 10 μm. (B) Area fraction of Lo phase in GUVs composed of 1:1 DOPC/DPPC and cholesterol, as a function of
cholesterol fraction. (C) Bursting rate (Yburst) as a function of the fraction of Lo phase in GUVs for various AzoTAB concentrations.
Figure 7. Suggested mechanism. (A) cis-AzoTAB does not insert in the membrane, and blue light-induced cis−trans isomerization does not affect
membrane stability. (B) trans-AzoTAB is hydrophobic enough to insert in the membrane. UV-induced trans−cis isomerization disturbs phospholipid
organization and leads to GUV bursting when the membrane is not fluid enough (presence of solid domains in the absence of cholesterol or high
fraction of Lo phase at high cholesterol concentration).
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the membrane is more fluid, that is, in the presence of a low
fraction of Lo phase. This could explain the increase in Yburst
with an increase in area fraction of Lo phase.
Figure 7 summarizes the possible mechanism explaining UV-
induced bursting in the presence of trans-AzoTAB and its
dependence on cholesterol fraction; cis-AzoTAB, which is less
hydrophobic than trans-AzoTAB, does not insert in the GUV
membrane, and blue light illumination does not induce any
bursting (Figure 7A). In contrast, trans-AzoTAB is hydrophobic
enough to insert in the membrane. When UV light is applied,
trans−cis isomerization disturbs the lipid organization, which
results in GUV bursting when the membrane is not fluid
enough to reorganize, that is, in the presence of solid domains
([Chol] = 0) or when a high fraction of Lo phase is present in
the membrane (high cholesterol concentration) (Figure 7B).
Since UV-induced bursting is related to the local isomer-
ization of AzoTAB in the GUV membrane, we studied the
response to the selective illumination of individual target GUVs
among others. To this end, UV illumination was performed
through a high-magnification objective lens (100× ) to get an
illumination area of about 300 μmi nd i a m e t e r .T h e
illumination was applied on a highly diluted suspension of
GUVs (10× more diluted than in former experiments) so that
the illumination area affects no more than one target GUV.
Figure 8 shows typical observations for GUVs composed of 40
mol % of cholesterol, which are the most sensitive to UV
illumination, according to Figure 3, exposed one by one to a
single UV illumination pulse (365 nm for 1 s). The first UV
pulse was applied to GUV “number 1”, which resulted in the
specific bursting of the target GUV while other GUVs in the
observation field remained intact. The same operation was
repeated successively to GUV “numbers 2 and 3” and resulted
each time in the selective bursting of the target vesicle. To our
knowledge, this is the first time that controlled bursting of
target individual GUVs among others is reported. Our light
stimulation thus enables both a fast response and a good spatial
resolution.
■ CONCLUSION
We have reported for the first time the use of UV light to
induce the bursting of multicomponent GUVs. This was
achieved with GUVs composed of 1:1 DOPC/DPPC and
various fractions of cholesterol in the presence of AzoTAB
photosensitive surfactant. We found that bursting was
particularly efficient in the absence of cholesterol or with
high cholesterol concentration. This non-monotonous choles-
terol effect was attributed to the role of membrane fluidity,
which modulates the ability of phospholipids to reorganize in
response to AzoTAB isomerization after the UV light stimulus.
The UV-induced response was demonstrated to be fast (less
than 1 s) and spatially resolved, which allowed us to control for
the first time the bursting of individual target GUVs among
others. In the future, these results could be applied to locally
probe biomembrane fluidity using light. It can also be useful for
the light-triggered release of solutes from artificial cell systems.
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(9) Römer, W.; Berland, L.; Chambon, V.; Gaus, K.; Windschiegl, B.;
Tenza, D.; Aly, M. R. E.; Fraisier, V.; Florent, J.-C.; Perrais, D.;
Lamaze, C.; Raposo, G.; Steinem, C.; Sens, P.; Bassereau, P.; Johannes,
L. Nature 2007, 450, 670.
(10) Osawa, M.; Anderson, D. E.; Erickson, H. P. Science 2008, 320,
792−294.
(11) Merkle, D.; Kahya, N.; Schwille, P. ChemBioChem 2008, 9,
2673−2681.
Figure 8. Selective UV-induced bursting of individual target GUVs. Phase contrast microscopy images of GUVs made of 1:1 DOPC/DPPC
containing 40 mol % cholesterol in the presence of AzoTAB (1 mM). GUVs pointed by arrows were successively illuminated by a single UV
illumination pulse (365 nm for 1 s) having a diameter of about 300 μm centered on the target GUV. Scale bars are 200 μm.
Journal of the American Chemical Society Article
dx.doi.org/10.1021/ja211664f | J. Am. Chem. Soc. 2012, 134, 4898−4904 4903(12) Pontani, L.-L.; Van der Gucht, J.; Salbreux, G.; Heuvingh, J.;
Joanny, J.-F.; Sykes, C. Biophys. J. 2009, 96, 192−198.
(13) Dietrich, C.; Bagatolli, L. A.; Volovyk, Z. N.; Thompson, N. L.;
Levi, M.; Jacobson, K.; Gratton, E. Biophys. J. 2001, 80, 1417−1428.
(14) Veatch, S. L.; Keller, S. L. Phys. Rev. Lett. 2002, 89, 268101.
(15) Baumgart, T.; Hess, S. T.; Webb, W. W. Nature 2003, 425,
821−824.
(16) Veatch, S. L.; Keller, S. L. Biophys. J. 2003, 85, 3074−3083.
(17) Collins, M. D.; Keller, S. L. Proc. Natl. Acad. Sci. U.S.A. 2008,
105, 124−128.
(18) Yu, Y.; Vroman, J. A.; Bae, S. C.; Granick, S. J. Am. Chem. Soc.
2010, 132, 195−201.
(19) Van den Bogaart, G.; Meyenberg, K.; Risselada, H. J.; Amin, H.;
Willig, K. I.; Hubrich, B. E.; Dier, M.; Hell, S. W.; Grubmüller, H.;
Diederichsen, U.; Jahn, R. Nature 2011, 479, 552−555.
(20) Käs, J.; Sackmann, E. Biophys. J. 1991, 60, 825−844.
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